ESLA
Estrella Immunopharma
$0.73
−$0.09 (−11.31%)Oct 29, 2026
Key metrics
The numbers that frame ESLA today
- Market cap
- $31.71M
- ROIC
- 105.4%
- Div yield
- 0%
- 52wk Low
- $0.24
- 52wk High
- $3.15
Growth
Revenue and earnings trend for ESLA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ESLA
Is Estrella Immunopharma a good buy?
No. Estrella Immunopharma has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Estrella Immunopharma is selling at a very high price.
What is the market capitalization of ESLA?
Estrella Immunopharma's market capitalization is $31.71M.
What is the 52-week high for ESLA stock?
The 52-week high for Estrella Immunopharma is $3.15. The current close of $0.73 is 76.9% below that high.
What is the 52-week low for ESLA stock?
The 52-week low for Estrella Immunopharma is $0.24. The current close of $0.73 is 203.8% above that low.
Does ESLA stock pay dividends?
Estrella Immunopharma does not currently show a dividend per share in the company data.